Journal
VIRUSES-BASEL
Volume 10, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/v10120688
Keywords
phages; phage therapy; Helsinki declaration; regulation; magistral preparation
Categories
Funding
- German Academy of Sciences Leopoldina
Ask authors/readers for more resources
The rise of multidrug-resistant bacteria has resulted in an increased interest in phage therapy, which historically preceded antibiotic treatment against bacterial infections. To date, there have been no reports of serious adverse events caused by phages. They have been successfully used to cure human diseases in Eastern Europe for many decades. More recently, clinical trials and case reports for a variety of indications have shown promising results. However, major hurdles to the introduction of phage therapy in the Western world are the regulatory and legal frameworks. Present regulations may take a decade or longer to be fulfilled. It is of urgent need to speed up the availability of phage therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available